In pancreatic cancer, targeting LIGHT for homing to tumor vessels via a vascular targeting peptide (VTP), LIGHT-VTP showed a dual ability to induce TLS formation and regulate the angiogenic vasculature (83). The gene discussed is TNFSF14; the disease is pancreatic neoplasm.